After concluding the project, the company has achieved
a clear understanding of the FDA requirements for the
Pre-market submission and they get the Pre-market
submission approval.
About this Case Study
The case study involved verifying GMP compliance in an IVD company to enable the commercialisation of their products in the USA.
A mock inspection was conducted based on 21 CFR 820 requirements, customized to the company’s IVD products and processes.
To learn more about the successful project and the comprehensive results achieved in verifying GMP compliance for the IVD company, download the full case study now.
Discover the step-by-step process, key improvements, and valuable insights that led to FDA pre-market submission approval
Download the Case Study
View other our other resources and company news
Blog How Rephine Accelerates Digital QMS Transformation in Pharma
Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
Blog Threat Modelling in Medical Devices: STRIDE for MDR/IVDR Cybersecurity Compliance
Understand how STRIDE and other threat modelling techniques help medical device manufacturers meet MDR/IVDR cybersecurity requirements—plus real-world examples and expert insights.
Read More
Guide Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper
Understand how to embed cybersecurity into the medical device lifecycle with this expert guide from Rephine. Includes MDR/IVDR, FDA, and IMDRF guidance on SRM, threat ...
Read More
Case Study Pharmaceutical Equipment Qualification Case Study
See how Rephine helped a global pharmaceutical manufacturer accelerate equipment qualification using a GMP-aligned, risk-based strategy—saving time and improving compliance.
Read More
Blog Equipment Qualification in the Pharmaceutical Industry: Lifecycle, Best Practices & Risk-Based Tips
Discover how to streamline equipment qualification in the pharmaceutical industry using a risk-based approach, modular documentation, and smart validation strategies. Learn practical tips to reduce ...
Read More
Blog Digitalization in Pharma: GxP Compliance with Rephine
Rephine enables pharma companies to transform digitally—ensuring GxP compliance, system validation (CSV), and data integrity across platforms like LIMS, MES, and QMS.
Read More
Blog Building a Strong Quality Culture in Pharma
A mature quality culture is more than compliance—it’s a business advantage. Explore how pharma companies can foster accountability, reduce risk, and embed quality into everyday ...
Read More
Blog Annex 1 Compliance: Sterile Manufacturing Updates Explained
The revised EU Annex 1 brings sweeping changes for sterile manufacturers. Learn what’s new, from contamination control to supplier audits, and how to prepare.
Read More
Blog Supplier Qualification in GxP Compliance: Strengthening Pharmaceutical Supply Chains
Supplier qualification is critical to GxP compliance and regulatory readiness. Discover how Rephine helps pharma companies manage supplier risks, ensure data integrity, and maintain supply ...
Read More